Targeting additional costimulatory pathways: a subtle role for CD2

Transplant Proc. 2001 Feb-Mar;33(1-2):199-200. doi: 10.1016/s0041-1345(00)01974-6.

Authors

C Dumont¹, O Deas, C Hebib, A Durrbach, F Hirsch, B Charpentier, A Senik

Affiliation

¹ Cell Immun Transplant Lab IRSC, CNRS ER 1984, Villejuif and Service de Néphrologie, University Hospital of Bicetre, Kremlin-Bicêtre, France.

PMID: 11266778
DOI: 10.1016/s0041-1345(00)01974-6

No abstract available

MeSH terms

Animals
Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / pharmacology*
CD2 Antigens / immunology*
CD2 Antigens / physiology
CD58 Antigens / physiology
Graft Rejection / drug therapy
Heart Transplantation / immunology
Humans
Immunity, Cellular
Immunosuppressive Agents / pharmacology*
Lymphocyte Activation / drug effects*
Mice
T-Lymphocytes / drug effects*
T-Lymphocytes / immunology
T-Lymphocytes, Cytotoxic / immunology
Transplantation Tolerance

Substances

Antibodies, Monoclonal
CD2 Antigens
CD58 Antigens
Immunosuppressive Agents
LO-CD2a